Literature DB >> 9613364

Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine.

F Ronchi1, P Cecchi, F Falcioni, A Marsciani, G Minak, G Muratori, P L Tazzari, S Beverini.   

Abstract

Three cases of immune thrombocytopenic purpura after the first dose of recombinant hepatitis B vaccine occurred in infants under 6 months of age. Other possible causes of this condition were excluded. Antiplatelet antibodies were present. A defect in platelet production was excluded in two children. Corticosteroid treatment was effective. Subsequent administration of other vaccines (against polio, diphtheria, and tetanus) did not cause relapse of thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9613364      PMCID: PMC1717498          DOI: 10.1136/adc.78.3.273

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

1.  Evans's syndrome triggered by recombinant hepatitis B vaccine.

Authors:  E Martínez; P Domingo
Journal:  Clin Infect Dis       Date:  1992-12       Impact factor: 9.079

2.  Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine.

Authors:  L Herroelen; J de Keyser; G Ebinger
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

3.  Liver dysfunction and DNA antibodies after hepatitis B vaccination.

Authors:  D Lilic; S K Ghosh
Journal:  Lancet       Date:  1994-11-05       Impact factor: 79.321

4.  Thrombocytopenic purpura after recombinant hepatitis B vaccine.

Authors:  P Poullin; B Gabriel
Journal:  Lancet       Date:  1994-11-05       Impact factor: 79.321

5.  Detection of platelet-associated antibodies by flow cytometry in hematological autoimmune disorders.

Authors:  P L Tazzari; F Ricci; N Vianelli; C Tassi; D Belletti; I Pierri; L Gugliotta; M Gobbi; R Conte
Journal:  Ann Hematol       Date:  1995-05       Impact factor: 3.673

  5 in total
  7 in total

1.  MMR vaccine and idiopathic thrombocytopaenic purpura.

Authors:  Corri Black; James A Kaye; Hershel Jick
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

Review 2.  Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.

Authors:  Carlo Perricone; Fulvia Ceccarelli; Gideon Nesher; Elisabetta Borella; Qasim Odeh; Fabrizio Conti; Yehuda Shoenfeld; Guido Valesini
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 3.  Safety of routine childhood vaccinations. An epidemiological review.

Authors:  R T Chen; G Mootrey; F DeStefano
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.930

4.  HBV vaccine and dermatomyositis: is there an association?

Authors:  Arie Altman; Martine Szyper-Kravitz; Yehuda Shoenfeld
Journal:  Rheumatol Int       Date:  2007-11-23       Impact factor: 3.580

5.  What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature?

Authors:  Graham E Ewing
Journal:  N Am J Med Sci       Date:  2009-07

Review 6.  Hepatitis B vaccination and associated oral manifestations: a non-systematic review of literature and case reports.

Authors:  B Tarakji; N Ashok; R Alakeel; Sn Azzeghaibi; A Umair; S Darwish; Rs Mahmoud; E Elkhatat
Journal:  Ann Med Health Sci Res       Date:  2014-11

Review 7.  A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.

Authors:  David B Huang; Jashin J Wu; Stephen K Tyring
Journal:  J Infect       Date:  2004-10       Impact factor: 6.072

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.